These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 7768290)
1. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. Jeziorski M; White FJ Eur J Pharmacol; 1995 Mar; 275(3):235-44. PubMed ID: 7768290 [TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. White FJ; Joshi A; Koeltzow TE; Hu XT Neuropsychopharmacology; 1998 Jan; 18(1):26-40. PubMed ID: 9408916 [TBL] [Abstract][Full Text] [Related]
3. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT. Mattingly BA; Himmler C; Bonta T; Rice LL Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612 [TBL] [Abstract][Full Text] [Related]
4. Impairments of movement initiation and execution induced by a blockade of dopamine D1 or D2 receptors are reversed by a blockade of N-methyl-D-aspartate receptors. Hauber W Neuroscience; 1996 Jul; 73(1):121-30. PubMed ID: 8783236 [TBL] [Abstract][Full Text] [Related]
5. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT; White FJ Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772 [TBL] [Abstract][Full Text] [Related]
6. Influence of acute or repeated restraint stress on morphine-induced locomotion: involvement of dopamine, opioid and glutamate receptors. del Rosario CN; Pacchioni AM; Cancela LM Behav Brain Res; 2002 Aug; 134(1-2):229-38. PubMed ID: 12191809 [TBL] [Abstract][Full Text] [Related]
7. Involvement of D1/D2 dopamine receptors within the nucleus accumbens and ventral tegmental area in the development of sensitization to antinociceptive effect of morphine. Reisi Z; Bani-Ardalan M; Zarepour L; Haghparast A Pharmacol Biochem Behav; 2014 Mar; 118():16-21. PubMed ID: 24418216 [TBL] [Abstract][Full Text] [Related]
8. Role of D₁/D₂ dopamin receptors antagonist perphenazine in morphine analgesia and tolerance in rats. Ozdemir E; Bagcivan I; Gursoy S Bosn J Basic Med Sci; 2013 May; 13(2):119-25. PubMed ID: 23725509 [TBL] [Abstract][Full Text] [Related]
9. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade. Ramos M; Goñi-Allo B; Aguirre N Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107 [TBL] [Abstract][Full Text] [Related]
10. D1-like and D2 dopamine receptor antagonists administered into the shell subregion of the rat nucleus accumbens decrease cocaine, but not food, reinforcement. Bari AA; Pierce RC Neuroscience; 2005; 135(3):959-68. PubMed ID: 16111825 [TBL] [Abstract][Full Text] [Related]
12. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens. Hoque KE; West AR Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069 [TBL] [Abstract][Full Text] [Related]
13. The effects of developmental cadmium exposure on morphine sensitization and challenge with selective D(1) and D(2) antagonists. Smith KR; Nation JR; Bratton GR Pharmacol Biochem Behav; 2002 Jun; 72(3):581-90. PubMed ID: 12175455 [TBL] [Abstract][Full Text] [Related]
14. Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats. Mohd-Yusof A; Veliz A; Rudberg KN; Stone MJ; Gonzalez AE; McDougall SA Psychopharmacology (Berl); 2016 Mar; 233(5):893-903. PubMed ID: 26650612 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice. Ralph RJ; Caine SB J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551 [TBL] [Abstract][Full Text] [Related]
16. Chronic morphine increases hippocampal acetylcholine release: possible relevance in drug dependence. Imperato A; Obinu MC; Casu MA; Mascia MS; Carta G; Gessa GL Eur J Pharmacol; 1996 Apr; 302(1-3):21-6. PubMed ID: 8790987 [TBL] [Abstract][Full Text] [Related]
17. D1 dopamine receptors modulate deltaFosB induction in rat striatum after intermittent morphine administration. Muller DL; Unterwald EM J Pharmacol Exp Ther; 2005 Jul; 314(1):148-54. PubMed ID: 15772255 [TBL] [Abstract][Full Text] [Related]
18. Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride. Wise RA; Carlezon WA Synapse; 1994 Jul; 17(3):155-9. PubMed ID: 7974197 [TBL] [Abstract][Full Text] [Related]
19. The effect of forced swim stress on morphine sensitization: Involvement of D1/D2-like dopamine receptors within the nucleus accumbens. Charmchi E; Zendehdel M; Haghparast A Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():92-9. PubMed ID: 27235796 [TBL] [Abstract][Full Text] [Related]
20. Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats. Kiyatkin EA; Rebec GV J Neurosci; 1999 May; 19(9):3594-609. PubMed ID: 10212318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]